Grant name: Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns
Funding organization: National Institutes of Health (NIH)
Total funding amount: Not specified
Duration: Maximum project period of 5 years
Primary objective: To support research on novel screening and therapeutic interventions for newborns.
Key stakeholders: NICHD, researchers, healthcare providers, and affected families.
Grant program context: Part of the Hunter Kelly Newborn Screening Research Program.
Funding source: NIH.
Funding type: Grant.
Significance: Addresses critical gaps in newborn screening and treatment.
Grant frequency: Recurring with multiple application deadlines.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City Governments
Indian/Native American Tribal Governments (both recognized and non-recognized)
Federal Government Agencies
Foreign Organizations and non-domestic components of U.S. Organizations.
Organizations must complete registrations in SAM, eRA Commons, and Grants.gov.
Principal Investigators must have an eRA Commons account.
Development of novel screening technologies and therapeutic interventions.
Research on conditions included in newborn screening panels or those that could benefit from early detection.
Improved screening and treatment outcomes for newborns.
Research addressing health disparities in medically underserved communities.
Expertise in basic, behavioral, translational, and clinical research.
All applications must include a Data Management and Sharing Plan.
Application budgets are not limited but must reflect actual project needs.
Open Date: January 5, 2025.
Multiple application deadlines through June 2027.
Compliance with NIH Grants Policy Statement and federal regulations.
Follow the instructions in the How to Apply - Application Guide.